135 related articles for article (PubMed ID: 1894448)
1. Solid phase synthesis of a fully active analogue of cholecystokinin using the acid-stable Boc-Phe (p-CH2) SO3H as a substitute for Boc-Tyr(SO3H) in CCK8.
Gonzalez-Muniz R; Cornille F; Bergeron F; Ficheux D; Pothier J; Durieux C; Roques BP
Int J Pept Protein Res; 1991 Apr; 37(4):331-40. PubMed ID: 1894448
[TBL] [Abstract][Full Text] [Related]
2. Full agonists of CCK8 containing a nonhydrolyzable sulfated tyrosine residue.
Marseigne I; Roy P; Dor A; Durieux C; Pélaprat D; Reibaud M; Blanchard JC; Roques BP
J Med Chem; 1989 Feb; 32(2):445-9. PubMed ID: 2464062
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of human CCK26-33 and CCK-33 related analogues on 2,4-DMBHA and TMBHA.
Miranda MT; Liddle RA; Rivier JE
J Med Chem; 1993 Jun; 36(12):1681-8. PubMed ID: 7685390
[TBL] [Abstract][Full Text] [Related]
6. Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor.
McCort-Tranchepain I; Ficheux D; Durieux C; Roques BP
Int J Pept Protein Res; 1992 Jan; 39(1):48-57. PubMed ID: 1378822
[TBL] [Abstract][Full Text] [Related]
7. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.
Charpentier B; Durieux C; Menant I; Roques BP
J Med Chem; 1987 Jun; 30(6):962-8. PubMed ID: 2438407
[TBL] [Abstract][Full Text] [Related]
8. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
[TBL] [Abstract][Full Text] [Related]
9. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
[TBL] [Abstract][Full Text] [Related]
10. Plant peptide hormone phytosulfokine (PSK-alpha): synthesis of new analogues and their biological evaluation.
Bahyrycz A; Matsubayashi Y; Ogawa M; Sakagami Y; Konopińska D
J Pept Sci; 2004 Jul; 10(7):462-9. PubMed ID: 15298181
[TBL] [Abstract][Full Text] [Related]
11. Facile solid-phase synthesis of sulfated tyrosine-containing peptides: total synthesis of human big gastrin-II and cholecystokinin (CCK)-39.
Kitagawa K; Aida C; Fujiwara H; Yagami T; Futaki S; Kogire M; Ida J; Inoue K
J Org Chem; 2001 Jan; 66(1):1-10. PubMed ID: 11429884
[TBL] [Abstract][Full Text] [Related]
12. Synthetic CCK8 analogs with antagonist activity on pancreatic receptors: in vivo study in the rat, compared to non-peptidic antagonists.
Nagain C; Galas MC; Lignon MF; Rodriguez M; Martinez J; Rozé C
Pancreas; 1991 May; 6(3):275-81. PubMed ID: 1713671
[TBL] [Abstract][Full Text] [Related]
13. Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues.
Tilley JW; Danho W; Lovey K; Wagner R; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S
J Med Chem; 1991 Mar; 34(3):1125-36. PubMed ID: 2002454
[TBL] [Abstract][Full Text] [Related]
14. Cyclic cholecystokinin analogues with high selectivity for central receptors.
Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
[TBL] [Abstract][Full Text] [Related]
15. Total synthesis, purification, and characterization of human [Phe(p-CH2SO 3Na)52, Nle32,53,56, Nal55]-CCK20-58, [Tyr52, Nle32,53,56, Nal55]-CCK-58, and [Phe(p-CH2SO3Na)52, Nle32,53,56, Nal55]-CCK-58.
Miranda MT; Craig AG; Miller C; Liddle RA; Rivier JE
J Protein Chem; 1993 Oct; 12(5):533-44. PubMed ID: 7511387
[TBL] [Abstract][Full Text] [Related]
16. Application of 2-chlorotrityl resin in solid phase synthesis of (Leu15)-gastrin I and unsulfated cholecystokinin octapeptide. Selective O-deprotection of tyrosine.
Barlos K; Gatos D; Kapolos S; Poulos C; Schäfer W; Yao WQ
Int J Pept Protein Res; 1991 Dec; 38(6):555-61. PubMed ID: 1819590
[TBL] [Abstract][Full Text] [Related]
17. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
Roosenburg S; Laverman P; Joosten L; Eek A; Oyen WJ; de Jong M; Rutjes FP; van Delft FL; Boerman OC
Bioconjug Chem; 2010 Apr; 21(4):663-70. PubMed ID: 20302291
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
19. Solid phase synthesis of peptides containing the non-hydrolysable analog of (O)phosphotyrosine, p(CH2PO3H2)Phe. Application to the synthesis of 344-357 sequences of the beta 2 adrenergic receptor.
Garbay-Jaureguiberry C; Ficheux D; Roques BP
Int J Pept Protein Res; 1992 Jun; 39(6):523-7. PubMed ID: 1383166
[TBL] [Abstract][Full Text] [Related]
20. A new series of photoactivatable and iodinatable linear vasopressin antagonists.
Carnazzi E; Aumelas A; Barberis C; Guillon G; Seyer R
J Med Chem; 1994 Jun; 37(12):1841-9. PubMed ID: 8021923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
